Intrastriatal hypoxanthine administration affects Na+,K+-ATPase, acetylcholinesterase and catalase activities in striatum, hippocampus and cerebral cortex of rats

International Journal of Developmental Neuroscience

Volumn 24, Issue 7, 2006, Pages 411-417

  Bavaresco, Caren Serra ^a   Chiarani, Fabria ^a   Wajner, Moacir ^a   Netto, Carlos Alexandre ^a   de Souza Wyse, Angela Terezinha ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Catalase; Hypoxanthine; Intrastriatal injection; Lesch Nyhan; Metabolic disease; Na+,K+ ATPase

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATALASE; HYPOXANTHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHRONOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME ASSAY; HIPPOCAMPUS; IN VITRO STUDY; LESCH NYHAN SYNDROME; METABOLITE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN;

ACETYLCHOLINESTERASE; ANIMALS; CATALASE; CEREBRAL CORTEX; CORPUS STRIATUM; HIPPOCAMPUS; HYPOXANTHINE; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33750039376     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2006.08.007     Document Type: Article

References (49)

1. Aebi H. Catalase in vitro. Meth. Enzymol. 105 (1984) 121-126
2. +-ATPase activity in rat striatum by metabolites accumulated in Lesch Nyhan disease. Int. J. Dev. Neurosci. 22 (2004) 11-17
3. +-ATPase activity and some parameters of oxidative stress in rat striatum. Brain Res. 1041 (2005) 198-204
4. +-ATPase activity and induces oxidative stress in the rats. Metab. Brain Dis.
5. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38 (1995) 357-366
6. Beckman J.S., Liu T.H., Hogan E.L., Freeman B.A., and Hsu C.Y. Oxygen free radicals and xanthine oxidase in cerebral ischemic injury in the rat. Soc. Neurosci. Abstr. 13 (1987) 1498
7. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-die binding. Anal. Biochem. 72 (1976) 248-254
8. +-stimulated ATPase activity. Anal. Biochem. 157 (1986) 375-380
9. Dasheiff R.M. Benzodiazepinic treatment for Lesch-Nyhan syndrome?. Dev. Med. Child. Neurol. 22 (1980) 101-102
10. Ellman G.I., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
11. Erecinska M., and Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 7 (1994) 21-29
12. Floyd R.A. Antioxidants, oxidative stress and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222 (1999) 236-245
13. Garcia-Alloza M., Gil-Bea F.J., Diez-Ariza M., Chen C.P., Francis P.T., Lasheras B., and Ramirez M.J. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 43 (2005) 442-449
14. Grafius M.A., Bond H.E., and Millar D.B. Acetylcholinesterase interaction with a lipoprotein matrix. Eur. J. Biochem. 22 (1971) 382-390
15. +-pump in epilepsy. Ann. Neurol. 16 (1984) 128-134
16. Halliwell B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 24 (1996) 1023-1027
17. Halliwell B., and Gutteridge J.M. The importance of free radicals and catalytic metal ions in human diseases. Mol. Asp. Med. 8 (1985) 89-193
18. Harkness R.A., McCreanor G.M., and Watts R.W. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and in urine with metabolite profiles in CSF. J. Inher. Metab. Dis. 11 (1988) 239-252
19. Heimer L., Zahm D.S., and Alheid G.F. Basal ganglia. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, London 579-628
20. Henderson J.F. Possible functions of hypoxanthine-guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch-Nyhan syndrome. Fed. Proc. 27 (1968) 1075-1077
21. Henderson V.W., Watt L., and Buckwalter J.G. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 21 (1996) 421-430
22. Hieber V., Siegel G.J., Fink D.J., Beaty M.W., and Mata M. Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system. Cell. Mol. Neurobiol. 11 (1991) 253-262
23. Horton J.W. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 189 (2003) 75-88
24. +)-ATPase activity by oxygen free radicals. Neuroreport 7 (1995) 333-337
25. Jinnah H.A., and Friedmann T. Lesch Nyhan disease and it variants. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 2537-2569
26. Jinnah H.A., and Gage F.H. Animal models of Lesch-Nyhan syndrome. Brain Res. Bull. 25 (1990) 467-475
27. Jones D.H., and Matus A.I. Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta 356 (1974) 276-287
28. Kisch S.J., Fox I.H., Kapur B.M., Lloyd K.G., and Hornykiewicz O. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan. Brain Res. 336 (1985) 117-123
29. Lassiter T.L., Barone Jr. S., and Padilla S. Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain. Brain Res. Dev. Brain Res. 105 (1998) 109-123
30. Lees G.J. Contributory mechanism in the causation of neurodegenerative disorders. Neuroscience 54 (1993) 287-322
31. Lloyd K.G., Hornykiewicz O., Davidson L., Shannak K., Farley I., Goldstein M., Shibuya M., Kelley W.N., and Fox I.H. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N. Engl. J. Med. 305 (1981) 1106-1111
32. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-267
33. Ma M.H.Y., Stacey N.C., and Connolly G.P. Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome. J. Neurosci. Res. 63 (2001) 500-508
34. Matthews W.S., Solan A., Barabas G., and Robey K. Cognitive functioning in Lesch-Nyhan syndrome: a 4-year follow-up study. Dev. Med. Child. Neurol. 41 (1999) 260-262
35. Mizuno T. Long-term follow-up of ten patients with Lesch-Nyhan syndrome. Neuropediatrics 17 (1986) 158-161
36. Nyhan W.L., Oliver W.J., and Lesch M. A familial disorder or uric acid metabolism and central nervous system function II. J. Pediatr. 67 (1965) 439-444
37. Oliveira P.J., Rolo A.P., Palmeira C.M., and Moreno A.J. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury. Cardiovasc. Toxicol. 1 (2001) 205-213
38. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
39. Puig J.G., Jimenez M.L., Mateos F.A., and Fox I.H. Adenine nucleotide turnover in hypoxanthine-guanine phosphoribosyl-transferase: evidence for an increased contribution of purine biosyntheses de novo. Metabolism 38 (1989) 410-418
40. Puig J.G., and Mateos F.A. The biochemical basis of HGPRT deficiency. In: Gresser U. (Ed). Molecular Genetics, Biochemistry and Clinical Aspects of Inherited Disorders of Purine and Pyrimidine Metabolism (1993), Springer-Verlag, New York 12-26
41. Rijksen G., Staal G.E.J., Van der Vlist M.J.M., Beerner F.A., Troost J., Gutensohn W., Van Laarhoven J.P.R.M., and De Bruyn C.H.M.M. Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Human Gen. 57 (1981) 39-47
42. Rosenbloom R.M., Henderson J.F., Caldwell I.C., Kelley W.N., and Seegmiller J.E. Inherited disorder of purine metabolism. JAMA 202 (1967) 175-177
43. Saito Y., and Takashima S. Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain Dev. 22 (2000) S122-S131
44. Stark G. Functional consequences of oxidative membrane damage. J. Membr. Biol. 205 (2005) 1-16
45. Travacio M., and Llesuy S. Antioxidant enzymes and their modification under oxidative stress conditions. Free Radic. Res. Latin Am. 48 (1996) 9-13
46. Villescas R., Ostwald R., Morimoto H., and Bennett E.L. Effects of neonatal undernutrition and cold stress on behavior and biochemical brain parameters in rats. J. Nutr. 111 (1981) 1103-1110
47. Visser J.E., Bär P.R., and Jinnah H.A. Lesch-Nyhan disease and the basal ganglia. Brain Res. Bull. 32 (2000) 449-475
48. Visser J.E., Smith D.W., Moy S.S., Breese G.R., Friedmann T., Rothstein J.D., and Jinnah H.A. Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res. Dev. Brain Res. 133 (2002) 127-139
49. +-ATPase activity after brain ischemia. Neurochem. Res. 25 (2000) 969-973